시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 체외진단용 효소 시장 보고서(2025년)
In Vitro Diagnostics Enzymes Global Market Report 2025
상품코드 : 1704588
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,387,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,232,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,077,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

체외진단용 효소 시장은 암 발병률 증가로 인해 큰 성장이 예상됩니다. 암은 세포의 비정상적인 증식과 분열을 특징으로 하는 질병군으로 건강한 조직에 위협이 되는 질환입니다. 암의 유병률 증가 요인으로는 감염, 면역체계의 기능 장애, 호르몬의 영향 등을 들 수 있습니다. 체외진단용(IVD) 효소는 암의 조기 발견 및 진단, 치료법 선택, 모니터링, 맞춤의료에 이르기까지 암 의료 전반에 걸친 다양한 진단 및 모니터링 분석에 중요한 역할을 하고 있습니다. 예를 들어, 세계보건기구(WHO)는 2050년까지 신규 암 환자가 2022년 대비 77% 증가할 것으로 예측하고 있으며, 암 관리에 체외진단용 효소의 필요성이 증가하고 있음을 강조하고 있습니다.

체외진단용 효소 시장의 주요 기업들은 시장 지위를 유지하기 위해 자가면역질환 검출 키트와 같은 혁신적인 제품에 투자하고 있습니다. 이러한 키트는 면역 체계가 신체 조직을 잘못 공격하는 자가 면역 질환을 감지하도록 설계되었습니다. 예를 들어, NeoDx Biotech Labs Pvt Ltd.는 최근 면역분석, 분자진단, 항체 검출법 등 첨단 기술을 통합한 자가면역질환 검출용 IVD 키트를 출시했습니다. 이 키트는 높은 민감도와 특이성을 가지고 있어 임상의가 자가면역질환을 신속하고 정확하게 진단할 수 있습니다.

2023년 2월, SD바이오센서와 SJL 파트너스(SJL Partners LLC)는 메리디안 바이오사이언스를 15억 3,000만 달러에 인수했습니다. 이번 인수를 통해 SD바이오센서는 메리디안의 진단약 및 면역학적, 분자학적 검사 원료에 대한 전문성을 다양한 용도로 활용할 수 있게 되었습니다. 미국에 본사를 둔 Meridian Bioscience Inc.는 체외 진단용 효소 및 관련 기술에 기여한 것으로 알려져 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

In vitro diagnostics (IVD) enzymes are specialized proteins used in diagnostic tests conducted outside the living organism, typically in a laboratory setting. These enzymes catalyze specific biochemical reactions that help detect, quantify, or monitor the presence of various substances, including pathogens, biomarkers, or other molecules relevant to diagnosing diseases.

The main enzyme types in the in vitro diagnostics enzymes market are proteases, polymerase and transcriptase, ribonuclease, and other enzyme types. Proteases refer to enzymes that catalyze the breakdown of proteins into smaller peptides or amino acids. Various disease types are targeted, including infectious diseases, diabetes, oncology, cardiology, nephrology, autoimmune diseases, and others. These enzymes are utilized in various technologies such as histology assays, molecular diagnostics, clinical chemistry, and others, and are used by end users such as pharmaceutical and biotech companies, hospitals and diagnostic labs, contract research organizations (CROs), and academic labs.

The in vitro diagnostics enzymes market research report is one of a series of new reports from The Business Research Company that provides in vitro diagnostics enzymes market statistics, including in vitro diagnostics enzymes industry global market size, regional shares, competitors with an in vitro diagnostics enzymes market share, detailed in vitro diagnostics enzymes market segments, market trends, and opportunities, and any further data you may need to thrive in the in vitro diagnostics enzymes industry. This in vitro diagnostics enzymes research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The in vitro diagnostics enzymes market size has grown strongly in recent years. It will grow from $2.14 billion in 2024 to $2.32 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing incidence of diseases such as cancer and HIV/AIDS, growing need for diagnostic testing and monitoring of age-related diseases, shifts in lifestyle factors, including diet and physical activity, rise in approval of new diagnostic assays and products by regulatory authorities, and higher healthcare expenditures globally.

The in vitro diagnostics enzymes market size is expected to see strong growth in the next few years. It will grow to $3.17 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing focus on personalized healthcare, growing healthcare infrastructure, rising disposable incomes in emerging markets, rise in collaborations between companies and research institutions, and increasing demand for rapid and convenient diagnostic solutions. Major trends in the forecast period include the adoption of microfluidics technologies, development of novel enzyme substrates and detection methods, use of point-of-care molecular diagnostic platforms integrated enzyme-based amplification techniques, integration of CRISPR-based technologies with enzyme assays, use of liquid biopsy techniques, and utilization of advanced data analytics and bioinformatics tools.

The in vitro diagnostics enzymes market is expected to grow significantly due to the rising prevalence of cancer. Cancer refers to a group of diseases characterized by abnormal cell growth and division, posing a threat to healthy tissues. Factors contributing to the increased prevalence of cancer include infectious agents, immune system dysfunctions, and hormonal influences. In vitro diagnostics (IVD) enzymes play a crucial role in various diagnostic and monitoring assays across the cancer care continuum, from early detection and diagnosis to treatment selection, monitoring, and personalized medicine. For example, the World Health Organization (WHO) projects a 77% increase in new cancer cases by 2050 compared to 2022, highlighting the growing need for in vitro diagnostics enzymes in cancer management.

Leading companies in the in vitro diagnostics enzymes market are investing in innovative products such as autoimmune disorder detection kits to maintain their market position. These kits are designed to detect autoimmune diseases, where the immune system mistakenly attacks the body's tissues. For instance, NeoDx Biotech Labs Pvt Ltd. recently launched an IVD kit for detecting autoimmune disorders, incorporating advanced technologies such as immunoassays, molecular diagnostics, and antibody detection methods. This kit offers high sensitivity and specificity, enabling clinicians to swiftly and accurately diagnose autoimmune conditions.

In February 2023, SD Biosensor Inc. and SJL Partners LLC acquired Meridian Bioscience Inc. for $1.53 billion. This acquisition allows SD Biosensor to leverage Meridian's expertise in diagnostic products and raw materials for immunological and molecular tests across various applications. Meridian Bioscience Inc., based in the US, is known for its contributions to in vitro diagnostic enzymes and related technologies.

Major companies operating in the in vitro diagnostics enzymes market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Grifols SA, Hologic Inc., Illumina Inc., Mindray Medical International Limited, PerkinElmer Inc., bioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin SpA, Promega Corporation, Randox Laboratories Ltd., Meridian Bioscience Inc., Fujirebio Diagnostics Inc., Sekisui Diagnostics LLC, Trivitron Healthcare, Codexis Inc., Amicogen Inc., EKF Diagnostics Holdings plc, Advanced Enzymes Technologies Ltd., Biocatalysts Ltd., Alpha Laboratories Ltd.

North America was the largest region in the in vitro diagnostics enzymes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostics enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro diagnostics enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in vitro diagnostics (IVD) enzymes market consists of revenues earned by entities by providing services such as enzyme engineering, custom enzyme production, validation services, promega custom assay services, and bio-techne enzyme solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The in vitro diagnostics (IVD) enzymes market also includes sales of Taq DNA polymerase, reverse transcriptase, alkaline phosphatase (ALP), horseradish peroxidase (HRP), DNA ligase, NEB enzyme products, and sigma-Aldrich diagnostic enzymes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostics Enzymes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in vitro diagnostics enzymes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for in vitro diagnostics enzymes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in vitro diagnostics enzymes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. In Vitro Diagnostics Enzymes Market Characteristics

3. In Vitro Diagnostics Enzymes Market Trends And Strategies

4. In Vitro Diagnostics Enzymes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global In Vitro Diagnostics Enzymes Growth Analysis And Strategic Analysis Framework

6. In Vitro Diagnostics Enzymes Market Segmentation

7. In Vitro Diagnostics Enzymes Market Regional And Country Analysis

8. Asia-Pacific In Vitro Diagnostics Enzymes Market

9. China In Vitro Diagnostics Enzymes Market

10. India In Vitro Diagnostics Enzymes Market

11. Japan In Vitro Diagnostics Enzymes Market

12. Australia In Vitro Diagnostics Enzymes Market

13. Indonesia In Vitro Diagnostics Enzymes Market

14. South Korea In Vitro Diagnostics Enzymes Market

15. Western Europe In Vitro Diagnostics Enzymes Market

16. UK In Vitro Diagnostics Enzymes Market

17. Germany In Vitro Diagnostics Enzymes Market

18. France In Vitro Diagnostics Enzymes Market

19. Italy In Vitro Diagnostics Enzymes Market

20. Spain In Vitro Diagnostics Enzymes Market

21. Eastern Europe In Vitro Diagnostics Enzymes Market

22. Russia In Vitro Diagnostics Enzymes Market

23. North America In Vitro Diagnostics Enzymes Market

24. USA In Vitro Diagnostics Enzymes Market

25. Canada In Vitro Diagnostics Enzymes Market

26. South America In Vitro Diagnostics Enzymes Market

27. Brazil In Vitro Diagnostics Enzymes Market

28. Middle East In Vitro Diagnostics Enzymes Market

29. Africa In Vitro Diagnostics Enzymes Market

30. In Vitro Diagnostics Enzymes Market Competitive Landscape And Company Profiles

31. In Vitro Diagnostics Enzymes Market Other Major And Innovative Companies

32. Global In Vitro Diagnostics Enzymes Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In Vitro Diagnostics Enzymes Market

34. Recent Developments In The In Vitro Diagnostics Enzymes Market

35. In Vitro Diagnostics Enzymes Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기